{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:28:45Z","timestamp":1788931725317,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Catheter ablation of ventricular arrhythmias (VA) has proven to be an effective therapeutic option for secondary arrhythmia prophylaxis. We sought to assess the procedural efficacy, safety and in-hospital mortality of a large patient cohort with and without structural heart disease undergoing VA ablation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1417 patients (804 patients with structural heart disease) undergoing 1792 endo- and epicardial procedures were analyzed. Multivariable risk factor analysis for occurrence of major complications and intrahospital mortality was obtained and a score to allow preprocedural risk assessment for patients undergoing VA ablation procedures was established.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Major complication occurred in 4.4% of all procedures and significantly more often in patients with structural heart disease than in structurally normal hearts (6.0 vs. 1.8%). The frequency of these periprocedural complications was significantly different between procedures with sole right ventricular and a combination of RV and LV access (0.5 vs. 3.1%). The most common complication was cardiac tamponade in 46 cases (3.0%). Intrahospital death was observed in 32 patients (1.8%). Logistic regression model revealed presence of ischemic heart disease, epicardial ablation, presence of oral anticoagulation or dual antiplatelet therapy as independent risk factors for the occurrence of complications or intrahospital death, while a history of previous heart surgery was an independent predictor with a decreased risk. Based on this analysis a risk score incorporating 5 standard variables was established to predict the occurrence of complications and intrahospital mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Safety of VA catheter ablation mainly relies on patient baseline characteristics and the type of access into the ventricles or epicardial space.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00392-021-01902-2","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T17:02:31Z","timestamp":1627405351000},"page":"530-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score"],"prefix":"10.1007","volume":"111","author":[{"given":"Shibu","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-7326","authenticated-orcid":false,"given":"Thomas","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Feickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wohlmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Wissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Richard","family":"Tilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-Hendrik","family":"Heeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rottner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Reissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rillig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Metzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Kuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"issue":"26","key":"1902_CR1","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657\u20132665","journal-title":"N Engl J Med"},{"issue":"9708","key":"1902_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr\u00e9taz E, VTACH Study Group et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)61755-4","journal-title":"Lancet"},{"issue":"2","key":"1902_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF et al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 375(2):111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1513614 (Epub 2016 May 5)","journal-title":"N Engl J Med"},{"issue":"3","key":"1902_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004422","volume":"10","author":"KH Kuck","year":"2017","unstructured":"Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS et al (2017) Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 10(3):e004422. https:\/\/doi.org\/10.1161\/CIRCEP.116.004422","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"1902_CR5","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.hrthm.2011.05.017","volume":"8","author":"M Bohnen","year":"2011","unstructured":"Bohnen M, Stevenson WG, Tedrow UB, Michaud GF, John RM, Epstein LM et al (2011) Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm 8(11):1661\u20131666. https:\/\/doi.org\/10.1016\/j.hrthm.2011.05.017 (Epub 2011 May 27)","journal-title":"Heart Rhythm"},{"issue":"4","key":"1902_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCEP.114.001530","volume":"7","author":"P Peichl","year":"2014","unstructured":"Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J (2014) Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol 7(4):684\u2013690. https:\/\/doi.org\/10.1161\/CIRCEP.114.001530 (Epub 2014 Jun 23)","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1902_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1161\/CIRCEP.115.002921","volume":"8","author":"S Gunda","year":"2015","unstructured":"Gunda S, Reddy M, Pillarisetti J, Atoui M, Badhwar N, Swarup V et al (2015) Differences in complication rates between large bore needle and a long micropuncture needle during epicardial access: time to change clinical practice? Circ Arrhythm Electrophysiol 8:890\u2013895. https:\/\/doi.org\/10.1161\/CIRCEP.115.002921","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1902_CR8","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.084","volume":"55","author":"F Sacher","year":"2010","unstructured":"Sacher F, Roberts-Thomson K, Maury P, Tedrow U, Nault I, Steven D et al (2010) Epicardial ventricular tachycardia ablation: a multicenter safety study. J Am Coll Cardiol 55:2366\u20132372. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.084","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1902_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010365","volume":"8","author":"S Mathew","year":"2019","unstructured":"Mathew S, Saguner AM, Schenker N, Kaiser L, Zhang P, Yashuiro Y et al (2019) Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a sequential approach. J Am Heart Assoc 8(5):e010365. https:\/\/doi.org\/10.1161\/JAHA.118.010365","journal-title":"J Am Heart Assoc"},{"key":"1902_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euz132","volume":"2019","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N et al (2019) HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 2019:euz132. https:\/\/doi.org\/10.1093\/europace\/euz132","journal-title":"Europace"},{"issue":"17","key":"1902_CR11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2017.02.044","volume":"69","author":"P Santangeli","year":"2017","unstructured":"Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS et al (2017) Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 69(17):2105\u20132115. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.044","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1902_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","volume":"8","author":"P Santangeli","year":"2015","unstructured":"Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD et al (2015) Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol 8(1):68\u201375. https:\/\/doi.org\/10.1161\/CIRCEP.114.002155 (Epub 2014 Dec 9)","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"1902_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.hrthm.2018.04.028","volume":"15","author":"D Muser","year":"2018","unstructured":"Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS et al (2018) Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm 15(10):1500\u20131506. https:\/\/doi.org\/10.1016\/j.hrthm.2018.04.028 (Epub 2018 May 10)","journal-title":"Heart Rhythm"},{"issue":"1","key":"1902_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10840-016-0168-8","volume":"48","author":"N Mathuria","year":"2017","unstructured":"Mathuria N, Wu G, Rojas-Delgado F, Shuraih M, Razavi M, Civitello A et al (2017) Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 48(1):27\u201334. https:\/\/doi.org\/10.1007\/s10840-016-0168-8 (Epub 2016 Aug 6)","journal-title":"J Interv Card Electrophysiol"},{"issue":"12","key":"1902_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006730","volume":"11","author":"P Vergara","year":"2018","unstructured":"Vergara P, Tzou WS, Tung R, Brombin C, Nonis A, Vaseghi M et al (2018) Predictive score for identifying survival and recurrence risk profiles in patients undergoing ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 11(12):e006730. https:\/\/doi.org\/10.1161\/CIRCEP.118.006730","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"1902_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.hrtm.2015.05.036.Epub2015May30","volume":"12","author":"R Tung","year":"2015","unstructured":"Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K et al (2015) Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study. Heart Rhythm 12(9):1997\u20132007. https:\/\/doi.org\/10.1016\/j.hrtm.2015.05.036.Epub2015May30","journal-title":"Heart Rhythm"},{"issue":"2","key":"1902_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/CIRCEP.114.002336.Epub2015Feb15","volume":"8","author":"DF Katz","year":"2015","unstructured":"Katz DF, Turakhia MP, Sauer WH, Tzou WS, Heath RR, Zipse MM et al (2015) Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records. Circ Arrhythm Electrophysiol 8(2):362\u2013370. https:\/\/doi.org\/10.1161\/CIRCEP.114.002336.Epub2015Feb15","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01902-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:10:33Z","timestamp":1651219833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01902-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1902"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01902-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SM received speaker\u2019s honoraria and travel grants from Medtronic and Biosense Webster. K-HK received research grants and personal fees from St. Jude Medical, Medtronic, and Biosense Webster. AM received speaker\u2019s honoraria and travel grants from Medtronic. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}